New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 7, 2014
07:29 EDTNBIXNeurocrine volatility may move on positive phase 2b study
Neurocrine option implied volatility may pick up following positive results of NBI-98854 in Kinect 2 study. Overall option implied volatility of 75 compares to its 26-week average of 79 according to Track Data, suggesting decreasing price movement.
News For NBIX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 31, 2014
10:51 EDTNBIXHigh option volume stocks
Subscribe for More Information
October 30, 2014
08:25 EDTNBIXNeurocrine receives Breakthrough Therapy Designation for dyskinesia candidate
Subscribe for More Information
October 20, 2014
16:07 EDTNBIXNeurocrine initiates Phase III study for VMAT2 Inhibitor NBI-98854
Subscribe for More Information
October 17, 2014
07:24 EDTNBIXNeurocrine management to meet with Deutsche Bank
Meeting to be held in Los Angeles on October 17 hosted by Deutsche Bank.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use